首页> 外文期刊>Brain research >PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.
【24h】

PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.

机译:PWZ-029是一种对包含α5亚基的GABA(A)受体具有中等反向激动剂功能选择性的化合物,可改善大鼠的被动学习能力,但不能提高主动学习能力。

获取原文
获取原文并翻译 | 示例
       

摘要

Benzodiazepine (BZ) site ligands affect vigilance, anxiety, memory processes, muscle tone and epileptogenic propensity through modulation of neurotransmission at GABA(A) receptors containing alpha1, alpha2, alpha3 or alpha5 subunits, and may have numerous experimental and clinical applications. The ability of non-selective BZ site inverse agonists to enhance cognition, documented in animal models and human studies, is clinically not feasible due to potentially unacceptable psychomotor effects. Most investigations to date have proposed the alpha1 and/or alpha5 subunit-containing GABA(A) receptors as comprising the memory-modulating population of these receptors. The novel ligand PWZ-029, which we synthesized and characterized electrophysiologically, possesses in vitro binding selectivity and moderate inverse agonist functional selectivity at alpha5-containing GABA(A) receptors. This ligand has also been examined in rats in the passive and active avoidance, spontaneous locomotor activity, elevated plus maze and grip strength tests, primarily predictive of the effects on the memory acquisition, basal locomotor activity, anxiety level and muscle tone, respectively. The improvement of task learning was detected at the dose of 5 mg/kg in the passive, but not active avoidance test. The inverse agonist PWZ-029 had no effect on anxiety or muscle tone, whereas at higher doses (10 and 20 mg/kg) it decreased locomotor activity. This effect was antagonized by flumazenil and also by the lower (but not the higher) dose of an agonist (SH-053-R-CH3-2'F) selective for GABA(A) receptors containing the alpha5 subunit. The hypolocomotor effect of PWZ-029 was not antagonized by the antagonist ss-CCt exhibiting a preferential affinity for alpha1-subunit-containing receptors. These data suggest that moderate negative modulation at GABA(A) receptors containing the alpha5 subunit is a sufficient condition for eliciting enhanced encoding/consolidation of declarative memory, while the influence of higher doses of modulators at these receptors on motor activity shows an intricate pattern whose relevance and mechanism await to be defined.
机译:苯二氮卓(BZ)位点配体通过调节GABA(A)受体中包含alpha1,alpha2,alpha3或alpha5亚基的神经递质来影响警惕,焦虑,记忆过程,肌肉张力和癫痫发生倾向,并且可能具有许多实验和临床应用。在动物模型和人体研究中记录的非选择性BZ位点反向激动剂增强认知的能力在临床上是不可行的,因为其潜在的精神运动作用可能无法接受。迄今为止,大多数研究已提出含α1和/或α5亚基的GABA(A)受体包括这些受体的记忆调节种群。我们通过电生理学对其进行合成和表征的新型配体PWZ-029在含有α5的GABA(A)受体上具有体外结合选择性和中等程度的反向激动剂功能选择性。还已经在大鼠的被动和主动回避,自发运动能力,升高的迷宫和抓地力测试中检查了该配体,主要预测了对记忆获得,基础运动能力,焦虑水平和肌张力的影响。在被动(而非主动)回避测试中,以5 mg / kg的剂量发现了任务学习的改善。反向激动剂PWZ-029对焦虑或肌张力没有影响,而在较高剂量(10和20 mg / kg)下,它会降低运动能力。氟马西尼和较低(但不是较高)剂量的对含有α5亚基的GABA(A)受体具有选择性的激动剂(SH-053-R-CH3-2'F)都可拮抗这种作用。 PWZ-029的低速运动作用并未被拮抗剂ss-CCt拮抗,后者对含α1-亚基的受体表现出优先的亲和力。这些数据表明,在含有α5亚基的GABA(A)受体上适度的负调节是引发声明性记忆增强编码/巩固的充分条件,而在这些受体上更高剂量的调节剂对运动活性的影响显示出一种复杂的模式,其相关性和机制有待定义。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号